Canaccord Genuity Maintains a 'Hold' on Amazon.com (AMZN); Expect Continued Low Margins; Drop PT to $210
Get Alerts AMZN Hot Sheet
Price: $259.45 -0.71%
Rating Summary:
68 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
68 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on Amazon.com (NASDAQ: AMZN) price target cut from $225 to $210.
Analyst, Michael Graham, said, "Amazon reported Q4 results that missed on the top line due primarily to European retail weakness and a faster shift toward third-party selling. Shipping and fulfillment costs also grew faster than sales, and we expect these trends to continue...While the stock is currently trading very close to its historical support level of 1.2x revenue, we believe these results may place this level on hold. We continue to look for an entry point closer to the end of the current investment cycle."
For an analyst ratings summary and ratings history on Amazon.com click here. For more ratings news on Amazon.com click here.
Shares of Amazon.com closed at $194.44 yesterday.
Analyst, Michael Graham, said, "Amazon reported Q4 results that missed on the top line due primarily to European retail weakness and a faster shift toward third-party selling. Shipping and fulfillment costs also grew faster than sales, and we expect these trends to continue...While the stock is currently trading very close to its historical support level of 1.2x revenue, we believe these results may place this level on hold. We continue to look for an entry point closer to the end of the current investment cycle."
For an analyst ratings summary and ratings history on Amazon.com click here. For more ratings news on Amazon.com click here.
Shares of Amazon.com closed at $194.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too.
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
- Raymond James Resumes Safehold (SAFE) at Market Perform
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share